Hubbard Radio Washington DC, LLC. All rights reserved. This website is not intended for users located within the European Economic Area.
Jeff Galvin, CEO and founder of American Gene Technologies, discusses how new technologies in the realm of gene therapy are able to use viruses to heal terminal illness. Galvin believes that, within the next ten years, a large swath of terminal cancers and monogenic diseases can be effectively treated with these methods.